BAY1143572
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BAY1143572, covering 2017-10-20 to 2018-06-25. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia [Phase 1]